Burning Rock Biotech Regains NASDAQ Compliance
Company Announcements

Burning Rock Biotech Regains NASDAQ Compliance

Burning Rock Biotech (BNR) has released an update.

Burning Rock Biotech Limited has announced that it is now in compliance with NASDAQ’s minimum bid price requirement after its share restructuring, which adjusted the ratio of its American depositary shares. The company successfully maintained a minimum closing bid price of $1.00 per share for over 10 consecutive business days. This achievement signifies the company’s regained stability and adherence to NASDAQ’s stringent listing standards.

For further insights into BNR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBurning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx
TipRanks Auto-Generated NewsdeskBurning Rock Biotech Announces Executive Changes
TheFlyBurning Rock Biotech CFO Leo Li resigns
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App